The following are some key points that we have chosen to highlight in connection with the report:

• Continued challenging market affected sales
• A decreased cost base to adapt to the slower sales
• Additional funding needed to leverage market potential

Read Analyst Group’s report comment here

About Analyst Group: One of Sweden's leading equity research boutiques with focus on small and medium-sized listed companies.
Read more about Analyst Group
 
This is a press release from Analyst Group regarding the publication of a comment on STENOCARE. Readers may assume that Analyst Group has received compensation for making the comment. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.